European Companies Search Engine

Wordmark: “LYNXTIV“ Euipotm 31 Jan 2019 European Union Intellectual Property Office (Trade Marks)

History

Text

Trade mark

Type Word
Name LYNXTIV
Filing number 017960410
Trade mark status REGISTERED
Nice Classification

5: Pharmaceutical preparations for use in humans, namely, chemotherapeutics and biopharmaceuticals; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology.

42: Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of cancer, autoimmune diseases, inflammatory disorders, gastroenterological disorders and for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation.

Filing date 25/09/2018
Registration date 30/01/2019
Expiry date 25/09/2028
Owners

Genmab A/S

???????? ?????? ??

DK-1560 København V

Denmark

The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Genmab A/S, Valby, Denmark.